Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Botanix Pharmaceuticals Limited ( (AU:BOT) ) has provided an update.
Insignia Financial Ltd has announced a change in its substantial holding in Botanix Pharmaceuticals Limited. As of January 9, 2025, Insignia’s voting power in Botanix has decreased from 10.34% to 9.32%, reflecting a shift in their investment position. This change may impact Botanix’s shareholder composition and market perception, potentially influencing future strategic decisions within the company.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development of dermatological products. The company is involved in innovative drug delivery systems and treatments for skin diseases, aiming to address unmet medical needs in the dermatology market.
YTD Price Performance: 12.64%
Average Trading Volume: 5,200,781
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$867.2M
For an in-depth examination of BOT stock, go to TipRanks’ Stock Analysis page.